A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASC30 Tablets in Participants With Obesity

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, and pharmacokinetics of ASC30 Tablets in participants with obesity.
Epistemonikos ID: 1d0409ac2a23b922ca8933a38a60f4161e15ec8e
First added on: Dec 01, 2024